488 Results

People

  1. Offit
    Offit
  2. Orlow
    Orlow
  3. Robson
    Robson
  4. Joseph
    Joseph
  5. Begg
    Begg
  6. Ladanyi
    Ladanyi
  7. Olson
    Olson
  8. Levine
    Levine
  9. Bernstein
    Bernstein
  10. Busam
    Busam

Groups

  1. GSK Faculty (194)
  2. Department of Medicine (173)
  3. Population Sciences Research Program (160)
  4. Solid Tumor Oncology Division (128)
  5. Survivorship Research (117)
  6. Epidemiology and Biostatistics (113)
  7. Department of Pathology and Laboratory Medicine (103)
  8. Sloan Kettering Institute Faculty (94)
  9. Center for Pancreatic Cancer Research (87)
  10. Clinical Genetics Service (77)
  1. "genetic variability"
Formats
  1. Journal Article (438)
  2. Review (21)
  3. Editorial (15)
  4. Research Letter (6)
  5. Correspondence (3)
  6. Guidelines (3)
  7. Book Section (1)
  8. Conference Paper (1)
Groups
  1. GSK Faculty (194)
  2. Department of Medicine (173)
  3. Population Sciences Research Program (160)
  4. Solid Tumor Oncology Division (128)
  5. Survivorship Research (117)
  6. Epidemiology and Biostatistics (113)

More Groups

People
  1. Kenneth Offit (64)
  2. Irene Orlow (28)
  3. Mark Robson (27)
  4. Vijai Joseph (24)
  5. Colin Begg (22)
  6. Zsofia Stadler (20)

More People

Years
  1. 2025 (13)
  2. 2024 (31)
  3. 2023 (23)
  4. 2022 (16)
  5. 2021 (11)
  6. 2020 (33)

More Years

Publications
  1. Nature Genetics (15)
  2. Clinical Cancer Research (14)
  3. Nature Communications (13)
  4. PLoS ONE (13)
  5. Proceedings of the National Academy of Sciences of the United States of America (13)
  6. Cancer Research (12)

More Publications

Publishers
  1. Nature Publishing Group (67)
  2. Elsevier Inc. (47)
  3. American Association for Cancer Research (38)
  4. Cell Press (24)
  5. Wiley Blackwell (24)
  6. Public Library of Science (23)

More Publishers

Results (488)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Homologous recombination–deficient mutation cluster in tumor suppressor RAD51C identified by comprehensive analysis of cancer variants
    Journal Article

    Prakash, R.; Rawal, Y.; Sullivan, M. R.; Grundy, M. K.; Bret, H.; Mihalevic, M. J.; Rein, H. L.; Baird, J. M.; Darrah, K.; Zhang, F.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2022)

    Fulltext@MSK | Save
  • Whole-genome sequencing of East Asian lung cancers reveals new germline pathogenic variants
    Editorial

    Mukherjee, S.; Carrot-Zhang, J.
    Cancer Cell (2022)

    Fulltext@MSK | Save
  • Fifty years of progress in surgical oncology: Melanoma
    Review

    Coit, D. G.; Ariyan, C. E.
    Journal of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Attitudes toward preimplantation genetic testing and quality of life among individuals with hereditary diffuse gastric cancer syndrome
    Journal Article

    Shah, I. H.; Salo-Mullen, E. E.; Amoroso, K. A.; Kelsen, D.; Stadler, Z. K.; Hamilton, J. G.
    Hereditary Cancer in Clinical Practice (2022)

    Fulltext@MSK | Save
  • Response to Mehta et al
    Correspondence

    Horak, P.; Chakravarty, D.; Sonkin, D.
    Genetics in Medicine (2022)

    Fulltext@MSK | Save
  • Revision of RUNX1 variant curation rules
    Editorial

    Feurstein, S.; Luo, X.; Shah, M.; Walker, T.; Mehta, N.; Wu, D.; Godley, L. A.; Feurstein, S.; on behalf of the Myeloid Malignancy Variant Curation Expert Panel
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Inherited TP53 variants and risk of prostate cancer
    Journal Article

    Maxwell, K. N.; Cheng, H. H.; Powers, J.; Gulati, R.; Ledet, E. M.; Morrison, C.; Le, A.; Hausler, R.; Stopfer, J.; Hyman, S.; more...
    European Urology (2022)

    Fulltext@MSK | Save
  • Costs and barriers of cancer screening after positive genetic testing: Are actionable mutations becoming unactionable?
    Editorial

    Kahn, R. M.; Gordhandas, S.; Aviki, E.; Long Roche, K.
    Journal of the National Comprehensive Cancer Network (2022)

    Fulltext@MSK | Save
  • A community approach to the cancer-variant-interpretation bottleneck
    Editorial

    Krysiak, K.; Danos, A. M.; Kiwala, S.; McMichael, J. F.; Coffman, A. C.; Barnell, E. K.; Sheta, L.; Saliba, J.; Grisdale, C. J.; Kujan, L.; more...
    Nature Cancer (2022)

    Fulltext@MSK | Save
  • Breast cancer screening strategies for women with ATM, CHEK2, and PALB2 pathogenic variants: A comparative modeling analysis
    Journal Article

    Lowry, K. P.; Geuzinge, H. A.; Stout, N. K.; Alagoz, O.; Hampton, J.; Kerlikowske, K.; de Koning, H. J.; Miglioretti, D. L.; van Ravesteyn, N. T.; Schechter, C.; more...
    JAMA Oncology (2022)

    Fulltext@MSK | Save